Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H29FN2O3 |
Molecular Weight | 363.4576 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C=CCN1CCC[C@@]1([H])CN=C(c2cc(CCCF)cc(c2OC)OC)O
InChI
InChIKey=OABRYNHZQBZDMG-DLGGVWGKSA-N
InChI=1S/C20H29FN2O3/c1-4-10-23-11-6-8-16(23)14-22-20(24)17-12-15(7-5-9-21)13-18(25-2)19(17)26-3/h4,12-13,16H,1,5-11,14H2,2-3H3,(H,22,24)/t16-/m0/s1/i21-1
Molecular Formula | C20H29FN2O3 |
Molecular Weight | 363.4576 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. | 1995 Apr |
|
18F-fallypride binding potential in patients with schizophrenia compared to healthy controls. | 2010 Sep |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 06:56:27 UTC 2021
by
admin
on
Sat Jun 26 06:56:27 UTC 2021
|
Record UNII |
ZF3G9J6G7I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
ZF3G9J6G7I
Created by
admin on Sat Jun 26 06:56:27 UTC 2021 , Edited by admin on Sat Jun 26 06:56:27 UTC 2021
|
PRIMARY | |||
|
166173-82-6
Created by
admin on Sat Jun 26 06:56:27 UTC 2021 , Edited by admin on Sat Jun 26 06:56:27 UTC 2021
|
PRIMARY | |||
|
449762
Created by
admin on Sat Jun 26 06:56:27 UTC 2021 , Edited by admin on Sat Jun 26 06:56:27 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->RADIOLIGAND |
Rat receptor
BINDING
Kd
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |